ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

NCI Formaldehyde Finding Criticized

March 7, 1986

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

Organization Can Compete For Both Major FCRC Contracts, RFP Out Next June

September 12, 1980

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

Construction Needs From NCI Said $40 Million Year For Four Years

June 9, 1978